UCB Ventures

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

UCB Ventures is an evergreen strategic corporate venture fund established in 2017 to further strengthen UCB's ability to create value from novel insights and technologies that can transform the lives of patients suffering from severe diseases.

Corporate venture armCambridge, MA, USAucbventures.comSince 2025-06-11

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$135M

across 1 round

LATEST ROUND

SpliceBio

Series B · $135M · 2025-06-11

CO-INVESTORS

named beside it

Feed/Investors

Investor

The rounds this investor is named on, who it invests beside, and where it shows up.

BUILT ON

Rounds

[ 1 ]

SpliceBio[ PART ]

SpliceBio develops next-generation gene therapies using their proprietary Protein Splicing platform, targeting diseases caused by mutations in large genes.

Series B$135M2025-06-112 [ HISTORY ]

Company	Round	Amount	Announced	Role
SpliceBio SpliceBio develops next-generation gene therapies using their proprietary Protein Splicing platform, targeting diseases caused by mutations in large genes.	Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$135M	2025-06-11	[ PART ]

UCB Ventures

Investor

Rounds

Co-investors

Sectors

Stages

UCB Ventures

Rounds

Co-investors

Sectors

Stages